Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOLIMUMAB vs GOLODIRSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GOLIMUMAB vs GOLODIRSEN: Safety Overview

Metric GOLIMUMAB GOLODIRSEN
Total FAERS Reports 69,222 406
Deaths Reported 4,866 5
Death Rate 7.0% 1.2%
Hospitalizations 15,471 53
Average Patient Age 53.0 yrs 15.0 yrs
% Female Patients 79.2% 0.0%
FDA Approval Date N/A Dec 12, 2019
Manufacturer Janssen Biotech, Inc. Sarepta Therapeutics, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription